The future of healthcare depends on the unified communication between patients and providers. Nuance’s platform integrates directly into University Hospital’s existing infrastructure and extends the capabilities of the EHR to accelerate the modernization of its ‘digital front door’ with access to real-time data that powers productive and personalized experiences.
With Nuance’s conversational AI, University Hospitals will have the resources to free up live agents’ time to deliver additional assistance when needed therefore increasing portal use and slashing call wait times in half.
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, has reached a significant milestone
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Boehringer Ingelheim said on Monday that its “double G” metabolic dysfunction-associated steatohepatitis (MASH) drug delivered positive topline results in a Phase II trial. The company
University Hospitals Taps Nuance to Improve Patient Engagement
by Jasmine Pennic Leave a Comment
What You Should Know:
Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing | Psychedelic Invest
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, has reached a significant milestone
Unpacking Trump’s latest picks for top health roles
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Boehringer Ingelheim unveils mid-stage win for glucagon/GLP-1 candidate for MASH, kindling PhIII plans
Boehringer Ingelheim said on Monday that its “double G” metabolic dysfunction-associated steatohepatitis (MASH) drug delivered positive topline results in a Phase II trial. The company